Vanguard Group’s Novartis NVS Stock Holding History

Vanguard Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10,490	Closed	-$871K	–	4156
2014 Q4	$871K	Hold	10,490	–	–	﹤0.01%	3570
2014 Q3	$885K	Buy	+10,490	New	+$849K	﹤0.01%	3547

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vanguard Group's NVS Position: Q1 2015 in Review

Vanguard Group sold out of Novartis (NVS) in Q1 2015, closing a stake of 10,490 shares — an estimated $871K sold.

Vanguard Group first reported a position in NVS in Q3 2014 and held it in 2 quarters. The position peaked at $885K in Q3 2014. 939 funds tracked by Wall St. Rank hold NVS as of Q1 2015.

Vanguard Group reported no remaining Novartis position as of Q1 2015 after selling out during the quarter.
Vanguard Group sold 10,490 Novartis shares in Q1 2015, an estimated $871K.
Vanguard Group first reported a position in Novartis in Q3 2014 and held it in 2 quarters.
Vanguard Group's Novartis position peaked at $885K in Q3 2014.
939 funds tracked by Wall St. Rank held Novartis as of Q1 2015.

Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.